Biosimilars Forum

Cutting edge strategies to tackle the global legal, regulatory and commercial challenges of biosimilars

Wednesday, January 25 to Thursday, January 26, 2012

Bloomsbury Hotel, London

Immac J. Thampoe, Managing Counsel, Biologics
Merck & Co (US)

Armin Ritzhaupt, Manager, Global Regulatory Affairs
Boehringer Ingelheim (Germany)

Mohamed Oubihi, Senior Manager, International Regulatory
Affairs, Biogen Idec (UK)

Harvinder Popli, Director and Head of In-licensing
Ranbaxy Laboratories (India)

Alexander Berghout, Medical and Scientifi c Advisor
Sandoz Biopharmaceuticals (Germany)

Lincoln Tsang, Partner, Arnold & Porter (UK)

Maria Manley, Partner, Head of the Regulatory Practice Bristows (UK)

George Schlich, Attorney, Schlich & Co (UK)

Hans Sauer, Associate General Counsel for Intellectual Property
Biotechnology Industry Organization (US)

Peter Embley, Associate Director, PPD

Sanya Sukduang, Patent Attorney, Finnegan (US)

Jeffrey P. Kushan, Partner, Sidley Austin (US)

Bert Oosting, Partner, Hogan Lovells (Netherlands)

Anthony Tridico, Patent Attorney, Finnegan (US)

Gerry Kamstra, Partner, Bird & Bird (UK)

Frank Landolt, VP Intellectual Property and Legal
Ablynx (Belgium)

Frank Burkert, European Patent Attorney, Bayer (Germany)

André Bourgouin, Vice President, Corporate Intellectual
Property, Ipsen (France)

Reiner Spieker, Patent Examiner, German Patent and Trademark
Office (DPMA) (Germany)

Courtenay Brinckerhoff, Partner, Foley & Lardner (US)

Bernd Liedert, Head of Immunopharmacology, Merck Serono (Germany)

Alex Kudrin, Medical Director, Takeda (UK)

Bruce S. Manheim and Anita Varma
Partners, Ropes & Gray (US)

John Quisel, Vice President and General Counsel
Acceleron (US)

Marjan Noor, Partner
Simmons & Simmons (UK)

Dan Hartley, Senior Vice President, Associate General Counsel
Shire (UK)

Vineet Kohli, Patent Counsel, Lundbeck (US)

Gillian Cannon, Vice President, Commercial Operations
Merck Bioventures (US)

Hartwig Gajek, Medical Director, Europe, Baxter Innovations (Austria)

Sandra Pohlman, Partner, df-mp (Germany)

Gareth Morgan, Partner, Winston & Strawn (UK)

Peter Feldschreiber, Barrister and Physician, 4 New Square (UK)

Thomas F. Gillespie III, IP Transactional Counsel
Emergent BioSolutions (US)